Ameriprise Financial Inc Neuronetics, Inc. Transaction History

Ameriprise Financial Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $494,390 - $1.24 Million	-79,484 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.15 - $17.25 $44,660 - $75,900	-4,400 Reduced 5.25%	79,484 $1.27 Million
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $889,170 - $1.78 Million	83,884 New	83,884 $1.04 Million
Q4 2019 Feb 14, 2020	SELL	$4.03 - $9.22 $242,803 - $555,495	-60,249 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $14,168 - $22,216	1,705 Added 2.91%	60,249 $501,000
Q2 2019 Aug 14, 2019	BUY	$9.0 - $17.2 $93,645 - $178,966	10,405 Added 21.61%	58,544 $732,000
Q1 2019 May 15, 2019	SELL	$13.6 - $19.58 $1,496 - $2,153	-110 Reduced 0.23%	48,139 $734,000
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $1,760 - $3,502	110 Added 0.23%	48,249 $933,000
Q3 2018 Nov 14, 2018	SELL	$24.32 - $37.54 $17,267 - $26,653	-710 Reduced 1.45%	48,139 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $1.3 Million - $1.36 Million	48,849 New	48,849 $1.3 Million

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $82.1M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.